2 nd International Neuro-Urology Meeting. Zürich, Switzerland I June 2013

Transcription

1 2 nd International Neuro-Urology Meeting Zürich, Switzerland I June 2013

2 URINARY INCONTINENCE* Important information on the use of BOTOX for neurogenic detrusor overactivity 1 *BOTOX is the only botulinum toxin type A approved for the treatment of urinary incontinence due to neurogenic detrusor overactivity associated with a neurological condition in adults Welcome Dear colleagues, dear friends It is our great honour and pleasure to invite you to attend the 2 nd International Neuro-Urology Meeting, which will be held in Zürich, Switzerland, from June Neurogenic urinary tract dysfunction is highly prevalent and affects the lives of millions of people worldwide. It has a major impact on quality of life and sexuality and, besides the debilitating manifestations for patients, it also imposes a substantial economic burden for every health care system. Neuro-Urology has become a well-established and highly recognized sub-speciality in the fi elds of Neurology and Urology. The world s leading experts in Neuro- Urology will provide an overview on this rapidly developing and exciting sub-speciality. This unique meeting combines conventional lectures, panel discussions, live urodynamics and live surgery. Emphasis is placed on the interactive component. There will be many opportunities to exchange thoughts, experiences and ideas and also to make new friendships. Neuro-Urology needs outstanding young researchers and clinicians they are the future! Therefore, we are delighted to advertise the Swiss Continence Foundation Award of Swiss francs honouring the best contribution of a young Neuro-Urology talent at the 2 nd International Neuro-Urology Meeting. We are extremely honoured to organize the 2 nd International Neuro-Urology Meeting and are looking forward to meeting you in Zürich. Best regards 1. Prescribing Information BOTOX Switzerland, June 2012 CH/0136/2013 Ass. Prof. Thomas M. Kessler Chairman Swiss Continence Foundation Dr. Ulrich Mehnert Vice-Chairman Swiss Continence Foundation

3 Programme I Thursday 13 June Welcome Ass. Prof. Thomas M. Kessler Swiss Continence Foundation Award Neurophysiology of the lower urinary tract and bowel Prof. William C. de Groat Biochemical and structural alterations in neurogenic lower urinary tract dysfunction Prof. Marcus J. Drake Tee break with exhibition Evaluation and treatment of neurogenic sexual dysfunction Prof. Jean-Jacques Wyndaele Evaluation and diagnosis of neurogenic lower urinary tract dysfunction Panel discussion: Prof. John P. Heesakkers, Prof. Helmut Madersbacher, Dr. Julian Shah, Prof. Jean-Jacques Wyndaele Tee break with exhibition Live urodynamics Panel discussion: Prof. John P. Heesakkers, Prof. Helmut Madersbacher, Dr. Julian Shah, Prof. Jean-Jacques Wyndaele Conservative therapy of neurogenic lower urinary tract dysfunction Prof. Emmanuel Chartier-Kastler for details please visit

4 Programme I Friday 14 June 2013 Programme I Friday 14 June Neurogenic bowel dysfunction: Evaluation and treatment Dr. Anton Emmanuel Live intradetrusor botulinum A toxin injections Prof. Prokar Dasgupta Ass. Prof. Daniel Max Schmid Advances in spinal cord injury research: From bench to bedside Coffee break with exhibition Prof. Martin E. Schwab Prof. Armin Curt Young talents in neuro-urology: Swiss Continence Foundation Award jury: Prof. Emmanuel Chartier-Kastler, Prof. Francisco Cruz, Prof. John P. Heesakkers, Ass. Prof. Thomas M. Kessler, Prof. Helmut Madersbacher Lunch with exhibition Live sacral neuromodulation Panel discussion: Prof. Francisco Cruz, Dr. Gustav Kiss, Prof. Helmut Madersbacher, Prof. Brigitte Schurch, Prof. Karl-Dietrich Sievert Ass. Prof. Thomas M. Kessler Advances in diagnostic tools in neuro-urology Dr. Ulrich Mehnert Ass. Prof. Martin Schubert Gala Dinner with Swiss Continence Foundation Award Restaurant Sonnenberg Botulinum toxin injections for treating neurogenic lower urinary tract dysfunction Electrical neuromodulation/-stimulation for treating neurogenic lower urinary tract dysfunction Prof. Francisco Cruz Prof. Helmut Madersbacher Tee break with exhibition

5 Programme I Saturday 15 June Live cystectomy and continent catheterizable reservoir Prof. Fiona C. Burkhard Panel discussion: Prof. Christopher R. Chapple, Prof. Emmanuel Chartier-Kastler, Prof. Prokar Dasgupta, Ass. Prof. Daniel Max Schmid, Dr. Julian Shah Multiple sclerosis, Parkinson s disease and multiple system atrophy Dr. Jalesh N. Panicker Spinal cord injury Prof. Jürgen Pannek A unique simplicity SpeediCath Compact Set for simpler everyday catheterisation Coffee break with exhibition Spina bifida and tethered cord Dr. Gustav Kiss Surgery for neurogenic lower urinary tract dysfunction Prof. Christopher R. Chapple Lunch with exhibition Controversies and trends in neuro-urology Prof. Karl-Dietrich Sievert How to manage neurogenic lower urinary tract and sexual dysfunction in daily practice: case presentations and step-by-step approach Panel discussion: Prof. Marcus J. Drake, Prof. Helmut Madersbacher, Dr. Jalesh Panicker, Dr. Julian Shah, Prof. Karl-Dietrich Sievert Conclusions Prof. William C. de Groat The only compact and discreet catheter with an integrated and sterile bag NEW CME credits SGGG 20 I SGN 20 I SGIM 18.5 I SGU 20.5 I ECMEC 14

6 Faculty Prof. Fiona C. Burkhard, University of Bern, Bern, Switzerland Prof. Christopher R. Chapple, Sheffield Teaching Hospital, Royal Hallamshire Hospital, Sheffield, UK Prof. Emmanuel Chartier-Kastler, Groupe Hospitalier Pitié-Salpêtrière, Pierre et Marie Curie Medical School, Paris, France Prof. Francisco Cruz, Hospital de S. Joao and Faculty of Medicine of Porto, Porto, Portugal Prof. Armin Curt, Spinal Cord Injury Center & Research, Balgrist University Hospital, Zürich, Switzerland Prof. Prokar Dasgupta, King s College and Guy s Hospital, London, UK Prof. Marcus J. Drake, University of Bristol, Bristol, UK Prof. William C. de Groat, University of Pittsburgh School of Medicine, Pittsburgh, USA Dr. Anton Emmanuel, Neurogastroenterology, University College Hospital, London, UK Prof. John P. Heesakkers, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands Ass. Prof. Thomas M. Kessler, Spinal Cord Injury Center & Research, Balgrist University Hospital, Zürich, Switzerland Dr. Gustav Kiss, University Hospital Innsbruck, Innsbruck, Austria Prof. Helmut Madersbacher, University Hospital Innsbruck, Innsbruck, Austria Dr. Ulrich Mehnert, Spinal Cord Injury Center & Research, Balgrist University Hospital, Zürich, Switzerland Prof. Jürgen Pannek, Swiss Paraplegic Center, Nottwil, Switzerland Dr. Jalesh N. Panicker, Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK Ass. Prof. Daniel Max Schmid, University Hospital Zürich, Zürich, Switzerland Ass. Prof. Martin Schubert, Spinal Cord Injury Center & Research, Balgrist University Hospital, Zürich, Switzerland Prof. Brigitte Schurch, University Hospital Lausanne, Lausanne, Switzerland Prof. Martin E. Schwab, University of Zürich and Swiss Federal Institute of Technology Zürich, Zürich, Switzerland Dr. Julian Shah, University College London Hospitals and Royal National Orthopaedic Hospital, London, UK Prof. Karl-Dietrich Sievert, Eberhard Karls University Tübingen, Tübingen, Germany Prof. Jean-Jacques Wyndaele, Antwerp University Hospital, Antwerp, Belgium Swiss Continence Foundation The Swiss Continence Foundation is a non-profit organization founded in April 2011 with the goal of supporting and advancing research and further education in the field of Neuro-Urology and functional urology. A central issue of the foundation is the considerable improvement in the quality of patient care and in the patients quality of life. In addition, the foundation s support in high-quality advanced training and education in the field of Neuro-Urology and functional urology is supposed to contribute to the distribution of the knowledge gained from research and science to physicians, nursing specialists and to the interested public. In order to achieve these goals we depend on your financial support and would be very pleased to receive a donation. Bank details of the Swiss Continence Foundation: Aargauische Kantonalbank IBAN: CH Kaiserstrasse 8, CH-4310 Rheinfelden BIC/Swift: KBAGCH22XXX

7 Details Attendance fee CHF 395 (including refreshments and lunches) CHF 90 for the Gala Dinner (excluding beverages) Venue University Hospital Zürich, Raemistrasse 100 CH-8091 Zürich, Phone: +41 (0) Room: Hörsaal Ost B10 A1 Bern, Basel Train Station Altstetten Central Station Zürich Chur Accommodation Adliswil You can make hotel reservations directly at our website Universitätsstrasse Zoo ETH University Hospital Zürich Uni Rämistrasse Bellevue Train Station Stadelhofen Witikon Opera house Train Station Tiefenbrunnen Directions to University Hospital Zürich By public transport We recommend using public transportation to get to the University Hospital. The tram stop is located right across from the main entry to the University Hospital. The following tram lines will take you to the University Hospital Zürich: From the central station/bahnhofstrasse: No. 6 in the direction of Zoo: tram stop ETH/Universitätsspital (3 rd stop, 6 minutes) No. 10 in the direction of Zürich Flughafen: tram stop ETH/Universitätsspital (3 rd stop, 6 minutes) From tram stop Bellevue: No. 9 in the direction of Hirzenbach: tram stop ETH/Universitätsspital (3 rd stop, 6 minutes) No. 5 in the direction of Zoo: tram stop Platte (3 rd stop, 5 minutes) By car We have a limited number of parking spaces. If at all possible, please use public transport. Limmat Sihl A3 Parade- platz Lake Zürich A1 Airport Kloten St. Gallen Zollikon The new Verify System is now available The innovative and discrete solution o to evaluate your patients for Sacral Neuromodulation on Therapy for pelvic floor dysfunctions. Verify before you treat Visit us at the Medtronic booth to experience the Verify System UC EE

8 Registration by Fax or Title First name Surname Address Postcode/City Country I will attend the Gala Dinner with guests (CHF 90 per person) Safe catheterisation in a clever package NEW LoFric Foldable into pocket size Adhesive tab on back Adjustable Insertion Grip Origo Instant activation Peel-open Discreet disposal 2013 Wellspect HealthCare, a DENTSPLY International Company. All rights reserved CHGB-1303 DENTSPLY IH SA Rue Galilée 6, CEI3, Y-Parc, 1400 Yverdon-les-Bains. Tél Fax

9 Main sponsor Co-sponsor Sponsor